The company said that through the first six weeks of the second quarter, same-unit neonatal unit volume declined 2 percent compared with the year-ago period.
Pediatrix now expects second-quarter earnings of between 77 and 80 cents per share. The company had previously projected 85 to 87 cents per share.
PDX has completed the cash acquisitions of neonatal and neonatal specialty physician practices in South Florida and El Paso. The incorporation of these pratices into PDX's net value is effective immediately.
PDX has sold its newborn metabolic screening laboratory and the StepOne product to PerkinElmer for an undisclosed amount.